4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-25-009840
CEO sold 25,350 shares at an average $84.95 ($2,153,373)
- CEO acquired 25,350 shares (option exercise)
- CEO gave 3,863 shares (gift)
- CEO gave 3,863 shares (gift)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Zovighian Bernard J · CEO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +25,350 | $59.26 | $1,502,157 | 106,326 | D |
| 2025-12-08 | Sale : show line 2 in the form 10b5-1 | −21,487 | $85.21 | $1,831,006 | 84,839 | D |
| 2025-12-09 | Gift : show line 3 in the form 10b5-1 | −3,863 | 80,976 | D | ||
| 2025-12-09 | Gift : show line 4 in the form 10b5-1 | +3,863 | 12,459.55 | I | ||
| 2025-12-10 | Sale : show line 5 in the form 10b5-1 | −3,863 | $83.45 | $322,367 | 8,596.55 | I |
| Open-market sales · 25,350 sh · avg $84.95 · $2,153,373 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-08 | Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −25,350 | 25,350 | D |
Loading xslF345X05/doc4.xml…